Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Histone H4 is one of four core histone proteins that are involved in the organization of DNA into chromatin.1 Histones are globular proteins with unstructured N-terminal tails and are subject to a variety of post-translational modifications, such as methylation, acetylation, phosphorylation, and citrullination, that can influence chromatin structure and regulate gene transcription.1,2 Trimethylation of histone H4 at lysine 20 (H4K20Me3) is enriched at pericentric heterochromatin and is associated with gene silencing.3 In senescent cells, H4K20Me3 is enriched at senescence-associated heterochromatin foci (SAHF), and levels of H4K20Me3 are increased in senescent cells compared with proliferating cells.4 H4K20Me3 levels are elevated in tumor tissue, compared with adjacent non-tumor tissue, isolated from patients with esophageal squamous cell carcinoma, and elevated H4K20Me3 levels are associated with lymph node involvement and poor prognosis in these patients.5 Cayman's Histone H4K20Me3 Monoclonal Antibody (RM208) can be used for ELISA, multiplex-based assay, and Western blot (WB) applications.
WARNING This product is not for human or veterinary use.
1. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184(2), 205-213 (2009).
2. Writing, erasing and reading histone lysine methylations. Exp. Mol. Med. 49(4), e324 (2017).
3. A silencing pathway to induce H3-
4. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol. 17(1), 158 (2016).
5. H3K9me3, H3K36me3, and H4K20me3 expression correlates with patient outcome in esophageal squamous cell carcinoma as epigenetic markers. Dig. Dis. Sci. 64(8), 2147-2157 (2019).